West Paces Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $863K | Sell |
6,717
-860
| -11% | -$101K | 0.14% | 75 |
|
|
2026
Q1 | $911K | Sell |
7,577
-145
| -2% | -$16.7K | 0.18% | 61 |
|
|
2025
Q4 | $813K | Sell |
7,722
-1,233
| -14% | -$116K | 0.16% | 71 |
|
|
2025
Q3 | $752K | Sell |
8,955
-8,911
| -50% | -$734K | 0.15% | 71 |
|
|
2025
Q2 | $1.41M | Sell |
17,866
-3,216
| -15% | -$256K | 0.3% | 42 |
|
|
2025
Q1 | $1.89M | Buy |
21,082
+2,201
| +12% | +$205K | 0.43% | 34 |
|
|
2024
Q4 | $1.88M | Sell |
18,881
-517
| -3% | -$53.3K | 0.46% | 33 |
|
|
2024
Q3 | $2.2M | Sell |
19,398
-91
| -0.5% | -$10.8K | 0.54% | 27 |
|
|
2024
Q2 | $2.41M | Sell |
19,489
-68
| -0.3% | -$8.76K | 0.63% | 24 |
|
|
2024
Q1 | $2.58M | Sell |
19,557
-754
| -4% | -$92.9K | 0.68% | 19 |
|
|
2023
Q4 | $2.21M | Sell |
20,311
-92
| -0.5% | -$9.55K | 0.62% | 23 |
|
|
2023
Q3 | $2.1M | Sell |
20,403
-1,318
| -6% | -$142K | 0.66% | 22 |
|
|
2023
Q2 | $2.51M | Sell |
21,721
-106
| -0.5% | -$12K | 0.74% | 20 |
|
|
2023
Q1 | $2.32M | Buy |
21,827
+321
| +1% | +$34.7K | 0.72% | 21 |
|
|
2022
Q4 | $2.39M | Buy |
21,506
+69
| +0.3% | +$7.05K | 0.76% | 20 |
|
|
2022
Q3 | $1.85M | Buy |
21,437
+14
| +0.1% | +$1.25K | 0.66% | 21 |
|
|
2022
Q2 | $1.95M | Buy |
21,423
+513
| +2% | +$45.5K | 0.66% | 23 |
|
|
2022
Q1 | $1.72M | Buy |
20,910
+1,454
| +7% | +$115K | 0.54% | 25 |
|
|
2021
Q4 | $1.49M | Sell |
19,456
-487
| -2% | -$38.8K | 0.47% | 33 |
|
|
2021
Q3 | $1.5M | Buy |
19,943
+544
| +3% | +$41.4K | 0.53% | 27 |
|
|
2021
Q2 | $1.51M | Sell |
19,399
-921
| -5% | -$68.5K | 0.55% | 27 |
|
|
2021
Q1 | $1.49M | Buy |
20,320
+1,222
| +6% | +$90.1K | 0.6% | 26 |
|
|
2020
Q4 | $1.49M | Buy |
19,098
+1,838
| +11% | +$141K | 0.66% | 23 |
|
|
2020
Q3 | $1.37M | Buy |
17,260
+3,250
| +23% | +$255K | 0.7% | 22 |
|
|
2020
Q2 | $1.03M | Buy |
14,010
+6,160
| +78% | +$464K | 0.56% | 33 |
|
|
2020
Q1 | $576K | Buy |
7,850
+3,428
| +78% | +$269K | 0.37% | 55 |
|
|
2019
Q4 | $384K | Buy |
4,422
+725
| +20% | +$59.5K | 0.21% | 81 |
|
|
2019
Q3 | $297K | Hold |
3,697
| – | – | 0.18% | 86 |
|
|
2019
Q2 | $296K | Hold |
3,697
| – | – | 0.18% | 88 |
|
|
2019
Q1 | $293K | Hold |
3,697
| – | – | 0.21% | 91 |
|
|
2018
Q4 | $270K | Hold |
3,697
| – | – | 0.21% | 93 |
|
|
2018
Q3 | $250K | Sell |
3,697
-56
| -1% | -$3.57K | 0.18% | 94 |
|
|
2018
Q2 | $217K | Buy |
3,753
+179
| +5% | +$10.1K | 0.16% | 97 |
|
|
2018
Q1 | $186K | Sell |
3,574
-4,411
| -55% | -$238K | 0.14% | 103 |
|
|
2017
Q4 | $429K | Sell |
7,985
-7,598
| -49% | -$421K | 0.32% | 72 |
|
|
2017
Q3 | $952K | Sell |
15,583
-222
| -1% | -$13.5K | 0.72% | 29 |
|
|
2017
Q2 | $967K | Sell |
15,805
-26
| -0.2% | -$1.58K | 0.77% | 27 |
|
|
2017
Q1 | $960K | Buy |
15,831
+596
| +4% | +$36.2K | 0.77% | 31 |
|
|
2016
Q4 | $856K | Buy |
+15,235
| New | +$892K | 0.8% | 25 |
|
Other funds holding MRK
ECSS
West Paces Advisors's MRK Position: Q2 2026 in Review
West Paces Advisors reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $101K and leaving 6,717 shares worth $863K. The position accounts for 0.14% of the portfolio, ranked #75.
West Paces Advisors first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.58M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- West Paces Advisors held 6,717 shares of Merck worth $863K as of Q2 2026.
- West Paces Advisors sold 860 Merck shares in Q2 2026, an estimated $101K.
- Merck made up 0.14% of West Paces Advisors's portfolio in Q2 2026, its #75 holding.
- West Paces Advisors first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- West Paces Advisors's Merck position peaked at $2.58M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.